Definitive Contract 36C26124C0031

Award Date 12/1/23
Potential Completion Date 11/30/28
Potential Value $132K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, is for an extended warranty on the FILMARRAY SYSTEM, a molecular diagnostic testing platform used for syndromic infectious disease identification. The $429,029.10 firm fixed-price delivery order was placed by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) VISN 12. Biofire Diagnostics is an experienced federal contractor, holding several indefinite delivery contracts and...
This federal contract award is for the BIOFIRE FILMARRAY MULTIPLEX PCR SYSTEM AND REAGENTS provided by Biofire Diagnostics LLC, a foreign-owned for-profit organization specializing in infectious disease testing. The $204,910.50 firm fixed-price purchase order was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 16. The contract has a completion date of September 30, 2018 and was awarded on August 30, 2018. No set-aside...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for a BIOFIRE MAINTENANCE AGREEMENT with a potential value of $102,301.17. The contract, awarded on June 30, 2017, provides maintenance services for Biofire systems through June 30, 2022. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to various...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a Blanket Purchase Agreement (BPA) call to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide FILMARRAY DIAGNOSTICS TESTING services. The contract has a potential value of $162,158.00 and a completion date of September 30, 2023. The contract is issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents,...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company, to provide COVID-19 lab tests and support services. The $173,870.64 contract has an ultimate completion date of September 30, 2025 and does not utilize any set-aside designations. Biofire Diagnostics holds several significant federal contract Indefinite Delivery Vehicles (IDVs) and BPAs with the VA,...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract is for the provision of Biofire's FilmArray Analyzer diagnostic tests, under a Blanket Purchase Agreement (BPA) call order against Biofire's GSA Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a firm...
This is a $151,055.55 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The award is for the Biofire Touch System and molecular diagnostic multiplex kits, which are used for syndromic infectious disease testing. This purchase is not associated with any set-aside designations. The award is part of Biofire's existing General Services Administration (GSA)...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a firm fixed price blanket purchase agreement to Biofire Diagnostics LLC for $156,363.20 to provide wide film array testing services inclusive of equipment, service, training, reagents, and other items needed to perform tests through September 30, 2023. Biofire Diagnostics LLC is a foreign owned, for-profit biotech company that specializes in syndromic infectious disease testing. This...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a Delivery Order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide EMERGENCY BIOFIRE FILM ARRAY diagnostic products. The $210,076.64 firm-fixed-price contract supports the Coronavirus COVID-19 National Interest Action and was issued against Biofire's existing GSA Federal Supply Schedule contract for in-vitro diagnostics. Biofire Diagnostics is a leader in syndromic infectious...

This is a $132,300.00 firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 21 of the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The contract is for the maintenance of Biofire's FilmArray diagnostic system over a base period plus four option years, with a final completion date of November 30, 2028.

Biofire Diagnostics LLC is a major provider of infectious disease testing products and services to federal agencies, including the VA, Department of Defense, Department of Health and Human Services, and Department of State. This contract is likely part of a broader effort by the VA to ensure continued access to Biofire's advanced molecular diagnostic capabilities for its healthcare facilities. No set-aside designation was used for this award.

Generated 11/9/24, 9:10 AM